pemvidutide vs semaglutide Safety and efficacy of 24 weeks of in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial A Big Week for GLP-1

Some patients worry about what happens if they stop the medication

While this falls outside standard protocols, it may work for people extremely sensitive to medication effects

However, no completed trial has examined the effect of GLP-1 RAs on cardiovascular events in patients with established CVD and overweight/obesity in the absence of type 2 diabetes

Average weight loss ranges from 1015% of body weight over 12 weeks with consistent semaglutide use, though individual timelines vary widely based on starting weight, genetics, and adherence

Tu C, Lu H, Zhou T, Zhang W, Deng L, Cao W, et al

But they tell only part of the story